CONFIRMED ATTENDEES INCLUDE:

203 Investment Partners
5AM Ventures
A C Binder Corp.
AbbVie, Inc.
Advaxis, Inc.
Advent Healthcare Ventures
Aethlon Medical, Inc.
Agenus, Inc.
Aisling Capital, LLC
Akemi Capital
Alpha Bronze
Altius Strategy Consulting
APS International
ArcLight Advisors LLC
Arcus Ventures
Asterias Biotherapeutics
Athyrium Capital Management
Aurgalys
Barracuda Finance LLC
Baxalta, Inc.
Bellicum Pharmaceuticals, Inc.
BeyondSpring Pharmaceuticals, Inc.
BioPharm Insight
BTIG, LLC
Cancer Research Institute
CBT Advisors
Celldex Therapeutics
Cellectar Biosciences, Inc.
Cellectis
Centre de Recherche Pierre Fabre
cj seligman& co.
Cleveland Clinic Foundation
CornerstoneCapital AG
Cowen and Company
Dabar Investment Associates
Daiichi Sankyo
Dawson James Securities, Inc.
Defined Health
Del Mar Pharmaceuticals
Eachwin Capital, LP
Edison Group
eFFECTOR Therapeutics, Inc.
EGB Advisors
Enso Ventures
Excellentia Global Partners
F. Hoffmann La Roche AG
FBR & Co.
Formula Pharmaceuticals, Inc.
FreeMind Group
F-star Biotechnology Ltd.
Fusion Pharmaceuticals
Gabelli & Company
Griffin Securities
Helsinn Therapeutics
Hercules Technology Growth Capital, Inc.
Immune Pharmaceuticals, Inc.
Index Ventures
Inovio Pharmaceuticals
Inovio Pharmaceuticals, Inc.
INSTITUT DE RECHERCHE PIERRE FABRE
IPF Partners
ISA Pharmaceuticals B.V.
J&J Innovation Centre-Boston
Jina Ventures, Inc.
JP Morgan
Karus Therapeutics Ltd
Katan Associates, Inc.
Ladenburg Thalmann
Landmark Angels, Inc.
Lauren Sciences, LLC
Lexington Capital Management
Little Gem Life Sciences
Livingston Securities
Loncar Investment, LLC
LSWorks LLC
Maxim Group
MayTech Capital Management
MD Anderson Cancer Center
Mediqventures
Mehta Partners, LLC
Merchant Liquidity Fund, LP
Merck KGaA
Mergermarket
Mirna Therapeutics, Inc.
Mizuho Bank
Moffitt Cancer Center
MPM Capital
MSF Capital Advisors
Nasdaq OMX
Network 1 Financial Securities, Inc.
Neumedicines Inc.
New Enterprise Associates
Noble Life Science Partners
Novartis Pharmaceuticals Corporation
NovaSecta Ltd.
NSIP LLC
NYS Innovation VC Fund (NYSIVCF)
OncoSec Medical, Inc.
Oppenheimer & Co., Inc.
Oxford Bioscience Partners
Park Avenue Capital
Pierre Fabre Fund for Innovation
QVT Financial LP
RA Capital Management
Raymond James Financial, Inc.
Regeneron Pharmaceuticals, Inc.
Remiges Ventures
Rockport Venture Partners
Roth Capital Partners, LLC
Silence Therapeutics PLC
Silicon Valley Bank
SMR Consulting GmbH
Stanphyl Capital
Sternberg Investments
Stifel Financial Corp.
SugarCone Biotech, LLC
Syzygy Therapeutics
Takeda Pharmaceuticals
The Astrologers Fund
Thomson Reuters
UBS
Vaccinex, Inc
Vector Capital Associates
Venn Therapeutics, LLC
Venture Valuation AG
Versant Ventures
Vinart Corp. Capital Management
WBB Capital
WBB Securities, LLC
Willow Tree Capital Group, Inc.
XBiotech USA, Inc.
Yale University
Yorkville Advisors, LLC
ZIOPHARM Oncology, Inc.